Prøve GULL - Gratis
How Gen Z's digital lifestyle is changing fintechs' ops
Mint Mumbai
|August 14, 2025
Fintechs are now tailoring features to win Gen Z early on in their financial journey
Buoyed by higher starting salaries and more disposable income, Gen Z—people born after 1996—are leading the transformation in the financial services business.
Fintechs such as e-commerce platform Flipkart-backed super.money, Grip Broking Pvt. Ltd, and Scapia Technology Pvt. Ltd, are now tailoring features to win them early in their financial journey. From product design shifting from long-term, rigid products to flexible, high-engagement tools matching younger users' short attention spans and appetite for control, fintechs are rethinking their offerings.
Stride Ventures and Anicut Capital-backed retail investment platform Grip Invest introduced the "sell anytime" feature in March, allowing investors to sell bonds at any time after holding them for two months.
Early results show improved retention, higher engagement, and lower customer acquisition costs. Grip's customer acquisition costs dropped by 25% as a result of higher conversion rates from new and existing users, according to Vaibhav Laddha, chief executive of the company.
"Most bonds are considered illiquid due to longer maturity periods. We launched the feature to create instant liquidity as the new generation is averse to long-term investment commitments," Laddha told Mint.
Denne historien er fra August 14, 2025-utgaven av Mint Mumbai.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Mumbai
Mint Mumbai
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Mint Mumbai
EC extends electoral roll revision by a week to II Dec; final list on 14 Feb
The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.
2 mins
December 01, 2025
Mint Mumbai
THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS
These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.
3 mins
December 01, 2025
Mint Mumbai
Green hydrogen: Fast fashion could help bump up demand
A boom in its use for clean synthetic inputs might make a difference
3 mins
December 01, 2025
Mint Mumbai
Let's be a bit more selective in using the word 'reforms'
Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.
3 mins
December 01, 2025
Mint Mumbai
As mid-cap alpha shrinks, should you consider passive strategies?
Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey
4 mins
December 01, 2025
Mint Mumbai
With $2.2 bn fund, ChrysCap has appetite for riskier bets
MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing
3 mins
December 01, 2025
Mint Mumbai
GDP growth of 8% plus: How to sustain this pace
Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships
2 mins
December 01, 2025
Mint Mumbai
INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES
Detection tools today are not universal or consistent across languages
5 mins
December 01, 2025
Mint Mumbai
APIs to innovation: Bulk drug makers ramp up CDMO bets
Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.
2 mins
December 01, 2025
Listen
Translate
Change font size

